The hormone melatonin is currently proposed by some investigators to be an efficient means for decreasing the impairing effects of jet lag. Eight healthy male subjects, aged 20 to 32, underwent a 9-hr advance shift in the isolation facility of our institute during two periods each of 15 days' duration. In a double-blind, crossover design, subjects took either melatonin or placebo at 1800 hr local time for 3 days before the time shift and at 1400 hr for 4 days afterwards. The time shift was simulated
on days 7 and 8 by shortening the sleep period by 6 hr and the following wake period by 3 hr. Body temperature was recorded every 90 min, and urine was collected at 3-hr intervals all day and night. Melatonin treatment enhanced the resynchronization speed of some, but not all, hormone and electrolyte excretion rates for several days after the time shift. The adaptation speed of the temperature rhythm significantly increased during one postshift day. In addition, the circadian temperature rhythm had a significantly higher amplitude under melatonin treatment than under placebo after the time displacement. For the placebo group, the rhythm of 6-hydroxymelatoninsulfate excretion exhibited an advance shift in five subjects, whereas the other three showed a delay shift, and adjustment did not achieve more than one-half of the expected value within 8 days. A significantly different adjustment could be observed in the melatonin-treated group: Seven subjects underwent an advance shift of the expected 9 hr within an average of 8 days. The results suggest that melatonin treatment can accelerate resynchronization of the melatonin excretion rhythm after eastward time zone transitions. The improvement is not, however, sufficiently great that we can recommend melatonin for the alleviation of jet lag.
The main pineal hormone melatonin is currently being proposed as an efficient means to reduce the impairing effects of jet lag Wever, 1989) . Melatonin secretion follows a circadian cycle, characterized by a rapid increase during the late evening hours, a peak after midnight, and a decrease during the late hours of sleep (Wurtman et al., 1968; Preslock, 1984) . Some authors have speculated that melatonin acts as a synchronizer for several other body functions (Arendt and Marks, 1983) , whereas other researchers have found that doses of exogenous melatonin do not act as a zeitgeber on the circadian system (Wever, 1985a) .
Recently, several studies have been conducted to investigate melatonin treatment as a powerful means for alleviating jet lag after transmeridian flight (Arendt et al., 1986; Nowak, 1988; Petry et al., 1989) . The results of these studies indicate a beneficial effect, mainly on psychological functions, but also on the circadian rhythms of a few endocrinological variables. However, the conclusions drawn from these studies suffer from their design: Either the number of subjects was too small (one in the study by Nowak, 1988) , or only subjective ratings were completed by the subjects (Petry et al., 1989) , or the sampling rates of physiological data were too low for calculating circadian parameters (Arendt et al., 1986 ). The lack of information has been recognized, and further investigations have been recommended (Arendt et al., 1986) . Since jet lag includes not only psychological symptoms, but also physiological functions (Klein et al., 1970; Klein and Wegmann, 1980; Wegmann and Klein, 1985) , it is necessary to verify the efficacy of melatonin treatment on the circadian system for different psychological functions, and, in particular, for physiological functions.
From studies of sleep and circadian rhythms in international aircrews, we know that eastward travel can lead to more pronounced disturbances than comparable westbound journeys (Graeber et al., 1986a,b; Wegmann et al., 1986) . After eastbound flights, the circadian system may be shifted by either a delay or an advance, depending on the number of time zones crossed and individual thresholds (Gundel and Wegmann, 1987) . Because an advance may shorten the symptoms of jet lag, compared with an &dquo;antidromic&dquo; delay, and because an administration of melatonin about 4 hr prior to its natural peak in the circadian cycle may induce an advance response, in the present study we simulated the eastward part of Arendt's field study in our simulation facility (see Klein, 1989) . To minimize disturbances of the circadian system by unexpected environmental circumstances, we chose to conduct the study in the laboratory, thus combining the advantages of a highly controlled laboratory investigation with the demands derived from the conditions of &dquo;real&dquo; life. Because of the time difference of 9 hr between San Francisco and Frankfurt, we changed Arendt's protocol by extending the number of &dquo;transmeridian&dquo; crossings by one time zone, and by fixing the sleep times. All other variables remained as similar as possible.
MATERIALS AND METHODS
Eight healthy male subjects, aged 20 to 32 (mean ± SD = 25.8 ± 4.0), underwent two 15-day periods of a nearly identical protocol in the isolation facility of our institute. This isolation laboratory is designed to accommodate eight subjects simultaneously and provides the necessary facilities for complete isolation from the outside for days or weeks. The facility consists of eight sleeping cabins, two bathrooms, a large living room, a kitchen, and several rooms for testing subjects and recording data. Subjects usually could communicate with each other, but not with the outside world, and gathered in the living room for leisure activities during the absence of experimental tasks. Leisure time usually included reading, writing, or watching movies and time-shifted television shows. All activities were monitored by the investigators, who worked on shift schedules.
The study was designed as a double-blind, crossover experiment. Thus, four of the subjects took 5 mg melatonin and four took a placebo during the first 15-day period. Melatonin and placebo administration was reversed during the second experimental period. The time between periods was 6 weeks. The experimental protocol contained a simulated 9-hr advance shift of the environmental time. Melatonin and placebo were administered at 1800 hr local time on 3 days before the shift. The time shift of 9 hr was simulated on days 7 and 8 by shortening the sleep period by 6 hr and the following wake period by 3 hr (this schedule corresponds closely to an eastbound flight between San Francisco and Frankfurt). After the shift, subjects took melatonin or placebo on 4 consecutive days at 1400 hr local time, which corresponded to 2300 hr shifted laboratory time.
The timing of the drug administration was chosen according to the protocol of Arendt et al. (1987) . The reason for a preshift of a potential zeitgeber (i.e., external melatonin) on days 5 to 7 by about 4 hr was to initiate a phase advance in circadian functions by means of an increase of the melatonin concentrations during earlier times of day, in order to accelerate the resynchronization of the system after the 9-hr time advance. The subjects had to keep the daily routine in the new simulated time zone for the remaining 8 days.
The light in the facility was provided by warm-color bulbs in the ceiling. In the test rooms, they generated 500 lux at maximum when a subject was looking directly into the light. In the living room and in the sleep rooms, the effective illumination (100-200 lux) was lower because of a low number of bulbs. This illumination was restricted to the wake period. The sleep periods were confined to a time interval of 9 hr between 2300 hr and 0800 hr local time (except for the day of the time shift) by keeping lights off. Reading lamps were not allowed. The sleep duration of 9 hr was chosen in order to enable the subjects to get enough sleep, because the sleep was interrupted twice per night for urine collection. During wake times, napping or lying on the bed was prohibited. Instead, the subjects had to stay in the living room (except for tests, which were conducted in neighboring test rooms). Activities were kept on a low level by prohibiting exercises or the playing of exciting games, in order to simulate the activity of airplane travelers. The daily routine (meal composition and mealtimes, measurements, and bedtimes) was identical for the two phases of the study. Caffeine consumption was prohibited.
Body temperature was recorded by means of a rectal probe every 90 min. Urine was collected at 3-hr intervals all day and night for the subsequent determination of excretion rates for conjugated and unconjugated 17-hydroxycorticosteroids (17-OHCS conj. and 17-OHCS unconj.); 6-hydroxymelatoninsulfate (6-OHMS); and calcium, potassium, and sodium. A computerized performance test series (duration 20 min) for the assessment of reaction times and errors was administered every 3 hr during wakefulness. The battery included a memory and search test (Folkard et al., 1976) , a logical reasoning test (Baddeley, 1968) , a spatial recognition test, and a tracking task. Sleep quantity and quality were reported in a daily log. In addition, every 3 hr during wake times, a questionnaire was presented to the subjects, containing a fatigue survey (Pearson and Byars, 1956) , the Stanford Sleepiness Scale (SSS; Hoddes et al., 1973) , and two 100-mm linear scales assessing tenseness and alertness.
The circadian parameters (daily mean, amplitude, and acrophase) of the body functions were examined by a complex demodulation technique (Priestley, 1981) , applying a 24-hr window with a resolution of 12 hr. This analytical technique produces a smooth trend that, to some extent, anticipates shifts that have not yet occurred. Therefore, alternatively, a sinusoidal function with a period of 24.0 hr was fitted in 3-hr steps to the data curves. This procedure sometimes can lead to estimates of circadian parameters (i.e., amplitudes and acrophases) that are very uncertain because of small F values of the analysis. Therefore, acrophases having F values with p's greater than 0.05 (e.g., less than 5.32 for d f = 1, 8; p > 0.05) were excluded from subsequent analyses.
The null hypotheses of the study were that external melatonin would have no influence on the course and speed of resynchronization (i.e., acrophases would shift at the same rates and amplitudes would change the same amount under experimental and control conditions). If the null hypothesis could be rejected, melatonin treatment data would be compared with placebo data by the one-tailed Wilcoxon matched-pairs, signed-ranks test for the determination of the significance of the differences.
RESULTS
Melatonin treatment enhanced the resynchronization speed of several body functions. Figures 1 and 2 illustrate temperature and potassium excretion rates for four individuals during the entire experiment under placebo (thick line) and melatonin (thin line) intake. The raw data very clearly show the disruptive effect of the time shift in the circadian variation of the two FIGURE 1. Raw data on individual potassium excretion (four out of eight subjects). Rates (in ~Lmol/ min) are indicated on the y axis; day numbers are given on the x axis. Black bars illustrate sleep periods; vertical lines indicate the time of the shift on day 7. Excretion rates under placebo are indicated by thick lines; those under melatonin are indicated by thin lines. Letters A, D, E, and G refer to individual subjects. FIGURE 2. Raw temperature data in degrees Celsius; conventions as in Figure 1 . body functions; however, temperature seemed to be more affected than potassium. In addition, differences between subjects in temperature were more obvious and pronounced than differences in potassium excretion rates. Whereas subjects A and E needed an extended time for recovery, subject D showed very rapid adaptation of his temperature rhythm to the shifted time. The rates of adjustment of the other subjects (e.g., G) lay between the extremes. Although minor fluctuations could already be detected before the time shift in the daily variations in excretion rates, and particularly in temperature rhythms, differences between treatment conditions (in rhythm acrophases and amplitudes) occurred mainly after the environmental 9-hr advance.
Overall, significant differences were found in acrophases and amplitudes, but seldom in mean levels, for the day of the time shift (day 7) and for several days after the shift. In addition, in at least two out of three subjects, resynchronization by partition (Aschoff, 1978; Folkard et al., 1982) under placebo could be changed to a normal, faster readjustment process by melatonin treatment, which caused advances in those circadian functions that were delayed in the placebo test (see Figs. 3 and 5, below). In addition, Table 1 summarizes the significant differences between the melatonin and placebo conditions. ACROPHASES After the time displacement, in nearly all cases acrophases were earlier under melatonin treatment, indicating a faster adaptation rate than under placebo conditions. In temperature rhythms (Fig. 3 ), significant differences occurred on only 1 day during the resynchronization period; however, they were already detected during the period of melatonin ingestion before the shift. On average, the differences amounted to between 0.9 and 1.3 hr when all subjects were taken into account. The greatest discrepancy between conditions was about 1.3 hr (n = 7) during the day immediately following the shift. In addition, the temperature curves (Fig. 2) showed divergent behavior under different conditions in one subject (subject A). Whereas under placebo conditions the temperature rhythm adapted by delaying 15 hr., melatonin treatment forced the rhythm to adjust by an advance (as the rhythms of the other subjects did).
Electrolyte excretion exhibited divergent behavior between treatment conditions for the three different parameters. With melatonin treatment, potassium and sodium excretion rates adapted significantly faster on the day of the shift, and 2 and 5 days after the time shift (Table 1 ). The maximum difference in acrophases between the two conditions was 3.1 hr in sodium (day 7) and 3.8 hr in potassium on the seventh day after the shift. In potassium, the melatonin-treated rhythm differed from the placebo until the end of the investigation, FIGURE 3. Shifts of temperature acrophases ( ± SD) relative to baseline time. Vertical lines represent changes of manipulation. Horizontal lines indicate position of acrophase during baseline days and after complete shift to the new environmental time (either by advance of 9 hr or by delay of 15 hr). and complete adjustment was reached only under melatonin ingestion. By contrast, calcium acrophases showed no difference between conditions for the entire experiment.
Acrophases of the hormone excretion rhythms showed the greatest differences between conditions. The circadian maxima of 17-OHCS (conj. as well as unconj.) and 6-OHMS excretion rates differed by as much as 4 hr between placebo and melatonin ingestion. In 17-OHCS conj. (Fig. 4 ), significant differences occurred on 6 days, with the greatest difference of 2.8 hr occurring on the sixth day after the shift. Unconj. 17-OHCS rhythm acrophases differed significantly on 4 postshift days (Table 1) , the greatest discrepancy occurring on day 13 (A = 4.3 hr on average).
During the last three posttreatment days, similar behavior could be observed in the 6-OHMS excretion rhythm (Fig. 5 ). The slope of the curve was derived by averaging individual values derived from the entire slope of the phase adjustment curves; thus the advancing, placebo-treated group also showed an apparent delay on day 9 (Fig. 5 ). If only advance responses to the shift of the daily environmental schedule were compared, the difference was 2.8 hr on day 2 after treatment and decreased only gradually by the end of the experimental period. When the antidromic behavior was taken into account, three subjects still exhibited a delay response under placebo conditions, as already observed in temperature rhythm; under melatonin treatment, only one subject kept the antidromic adaptation course. Thus, advance and delay responses in 6-OHMS excretion rhythms can be summarized as follows: Acrophases differed significantly among conditions during the last 3 days (days 13 to 15) of the experimental phases (of course, no comparisons were made for melatonin ingestion days; day 12 was excluded from the analyses due to increased mean levels indicating an incomplete washout FIGURE 4. Shifts of conj. 17-OHCS excretion rate acrophases ( ± SD) relative to baseline position (for further explanation, see Fig. 3 ).
FIGURE 5. Shifts of 6-OHMS excretion rate acrophases ( ± SD ) relative to baseline position (for further explanation, see Fig. 3 ). Note. Baseline periods were days 2 to 4 (melatonin administration) and days 2 to 7 (placebo administration). Delay response of the corresponding rhythm during placebo administration is indicated by an asterisk. Subject E also did not respond by advance during melatonin administration. of the drug), resulting in a nearly complete adaptation to the new environmental time only after melatonin ingestion. In one subject (E), the 6-OHMS rhythm seemed to achieve readjustment by delaying very slowly under melatonin ingestion, but it could not be determined with certainty whether readaptation progresses by delay or advance. In this case, the resynchronization was slowed down by melatonin treatment.
The acrophases of the pretreatment on preshift days may give an indication of the interindividual response to the experimental protocol. When the acrophases of 6-OHMS and temperature from days 2 to 4 (melatonin) and days 2 to 7 (placebo) were averaged for each subject, the results diverged between subjects (Table 2 ). The range was 3.2 hr for 6-OHMS and 2.4 hr for temperature phases when the earliest and the latest acrophases were compared. The 6-OHMS rhythm, which peaked relatively late (subjects A, E, and F), responded by a delay to the 9-hr advance of the sleep-wake cycle under placebo conditions. The subject with the latest acrophase (subject E) could not be subjected to an advance response of his melatonin rhythm by the intervention, as mentioned before.
AMPLITUDES
Like the acrophases, the daily amplitudes of many functions responded in such a manner that the melatonin treatment aided the adaptation of the circadian system to the time shift. In most of these functions, 24-hr amplitudes did not often differ from baseline values in the melatonin treatment condition. Indeed, some even showed an increase in amplitude instead of the decrease observed in the placebo group. Thus, not only did amplitudes differ significantly between the two experimental conditions, but comparisons between baseline values averaged for each individual, and those derived after the time shift, also revealed that melatonintreated rhythms recuperated earlier from the sudden change of environmental synchronizers.
Temperature amplitudes were considerably higher on 2 days after the shift when melatonintreated, thus coming into normal range (as derived from the baseline days) on the fourth day afterwards, whereas under placebo conditions amplitudes reached normalization on the seventh day of the resynchronization period at the earliest. As a consequence, amplitudes showed significant differences in the placebo group on days 8-12 (p ~ 0.01 [day 8], p --0.05 [days 9-12]; Wilcoxon matched-pairs, signed-rank test, one-tailed) when compared with baseline, whereas the melatonin group differed from baseline only on days 8 (p 0 .01) and 9 (p ~ 0.05).
The amplitudes of electrolyte excretion rhythms were enhanced on several days, but significantly only in sodium and potassium (Fig. 6) . The difference was significant on 4 days for each function, although not on the same 24-hr periods before and during the resynchronization period. In general, recovery of the amplitudes was faster in sodium, as indicated by the fact that distinct changes from baseline occurred only on days 11 and 13 (p ~ 0.05) and only under placebo. In potassium, amplitudes did not return to normal under placebo within the remaining days of the experiment; that is, they differed significantly from baseline values on days 8 and 10-15 (p ~ 0.005 [days 8, 12, 13, and For hormones, some differences could be observed between conditions, depending on the body function. In 17-OHCS conj., amplitudes were significantly higher on 4 days when placebo and melatonin groups were compared; values reached normalization earlier under melatonin treatment, as also indicated by significant differences from baseline amplitudes only on days 10 and 11, whereas in the placebo group differences occurred on 5 days after the shift (p ~ 0.005 [days 8, 10, 11, and 12], p ~ 0.01 [day 13]). In contrast, amplitudes of 6-OHMS (on days without treatment) showed a difference only on day 14 between the two conditions. The latter body function showed a remarkable decrease in its diurnal level. Mean values of days 9, 10, and 11 differed significantly from subjects' averaged baseline FIGURE 6. Circadian amplitudes of ( ± SD) of potassium excretion rates. Vertical lines indicate changes of manipulation. Black vertical bars represent the melatonin condition; white bars represent the placebo condition. Significant differences are indicated as follows: * p --0.05; ** p --0.01 (Wilcoxon matchedpairs, signed-ranks test). values (p ~ 0.05 [days 9 and 10], p ~ 0.01 [day 11]; Wilcoxon matched-pairs, signedranks test).
SUBJECTIVE RATINGS
No differences were found either in sleep log data (i.e., the sleep quantity and quality were rated to be similar with and without melatonin treatment) or in subjective ratings, except alertness (100-mm scale). During the day after the shift (after only 3 hr of sleep and during a shortened wake period), subjects felt significantly more alert (p ~ 0.05) when ingesting melatonin than when ingesting placebo, although no significant change was detected in subjective sleep parameters. The difference in alertness was caused by decreased values in the placebo group when compared to baseline, whereas only a slight change was observed in the melatonin-treated group.
PERFORMANCE TESTS
The reaction time response curve for all performance tests clearly showed an extended learning phase. After more than 8 days (i.e., 50 test sessions) of the first experimental phase, reaction time had not yet reached a steady state. Because of this and the small size of changes, significant differences in performance between the two conditions could not be demonstrated.
DISCUSSION
As a prerequisite for the determination of the effectiveness of melatonin treatment on circadian desynchronization, other sources of potential influence must be excluded or minimized. In particular, light intensity appears to play an important role in the suppression of melatonin secretion (Lewy et al., 1980) . Because the intention of the present study was to influence the circadian system by external melatonin, light was kept in a range that was expected to have no adverse effects on the secretion of natural melatonin. Of course, we cannot exclude the potential impact of light exposure when the threshold of an individual is very low (Bojkowski et al., 1987) . Therefore, and also in order to counterbalance further disturbing influences, the maintenance of identical (or at least similar) experimental conditions had to be guaranteed for the entire experiment. A considerable effort was made in the study to satisfy these goals. Apart from the usual constraints of a crossover, double-blind design, a diet was selected and controlled that had minimal effects on the rhythms of hormones and electrolytes. Physical exercise was not permitted, and showers were restricted in number, duration, and water temperature, in order to minimize the impact of masking effects. In addition, during wake times, body temperature was recorded after the subjects had been seated for at least 20 min. The design of the study was planned and conducted to be the same for the two phases of the experiment. Unavoidable masking effects, which occurred during the first part, should have occurred to the same extent and at the same time of day during the second part. For that purpose, the daily schedule was kept strictly identical in the two parts of the study, including the order and composition of meals.
With these prerequisites fulfilled, the results of the study do indeed suggest that melatonin treatment affects the circadian system. The influence manifests itself in enhancing the re-synchronization speed of most recorded rhythmic functions, and mainly affects circadian amplitudes and acrophases. Although not all circadian parameters exhibited a significantly altered response to the simulated time zone transition under the two different conditions, those acrophases that did were earlier under melatonin treatment during the most critical days after the shift. In the temperature rhythm, an advance of the circadian rhythm was observed even before the time shift. This advance could be expected, because melatonin was administered about 4 hr earlier than the natural secretion peaks occurred. Following the time displacement, the largest acceleration was 4 hr for the body function most influenced by the melatonin treatment (i.e., 17-OHCS unconj. excretion rates), whereas no difference in resynchronization velocity could be detected in other body functions (e.g., calcium excretion rates). As a consequence, internal dissociation (Aschoff, 1978; Wever, 1979) associated with time zone transitions can be altered by melatonin treatment. Because the circadian rhythms that react very slowly to sudden phase displacements under normal conditions (potassium and 17-OHCS excretion; Wegmann et al., 1983; Samel and Wegmann, 1987) were also those most influenced by melatonin treatment, the internal dissociation was reduced. Furthermore, the resynchronization by partition (Aschoff, 1978; Folkard et al., 1982) , which occurred in three subjects and which delayed the readaptation process, was altered in at least two individuals to faster readjustment by forcing the circadian rhythm of the &dquo;antidromic functions&dquo; into an advance course. In one subject, however, the treatment produced an adverse effect: The speed of resynchronization slowed down after melatonin ingestion.
The mechanism of action on the circadian system of different individuals can be explained in terms of a simulation model (Gundel and Wegmann, 1989) . A shift between +8 and + 10 hr (advance) seems to be the most critical (Fig. 2 of Gundel and Wegmann, 1989) when one is manipulating the circadian system by changing external zeitgebers. When the influence of melatonin intake is supposed to be a contributing factor for increasing the external forces on the circadian system, the system is pushed to follow an advance course, converting antidromic resynchronization into a readaptation process in accordance with the external shift (as was seen for two subjects). The change of the direction of re-entrainment was first shown in rats by Armstong and Redman (1985) . For the remaining subject in the present study who exhibited a further delay of his 6-OHMS readjustment, the treatment was not sufficient to overcome the critical shift. The results of the study do not reveal conclusively whether the dose of melatonin or the time of application was critical for this subject. The daily excretion process (washout) of the drug was comparable to that of the other subjects (Nickelsen et al., 1991) . Therefore, the timing of melatonin ingestion seems to be very important for the course of resynchronization, as shown by Lewy et al. (1991) . We assume that subject E received the melatonin treatment too early in his circadian cycle, and therefore that the effect of external melatonin conflicted with the advance shift of the light-dark cycle instead of supporting it.
Not only acrophases were affected by melatonin treatment. Circadian amplitudes also showed improved readjustment to normal values after the advance shift of the environmental time. For the majority of body functions, the results of comparing amplitudes between baseline and recovery days, as well as the frequent occurrence of significant differences between melatonin and placebo ingestion conditions, supports the conclusion that melatonin treatment forces an earlier resynchronization of the circadian system. Those circadian rhythms that can be easily manipulated due to masking effects (Wever, 1985b; Samel and Wegmann, 1987) , were only slightly affected, if at all, whereas those that have the slowest resynchronization course after phase shifts (Wegmann et al., 1983) were affected most. In this context, it becomes debatable which body function best represents the circadian system. Although melatonin is less influenced by masking than other circadian markers, it can be manipulated by light (Lewy et al., 1980 (Lewy et al., , 1987 Bojkowski et al., 1987) , which is also used as a zeitgeber (Wever et al., 1983; Daan and Lewy, 1984; Czeisler et al., 1986 Czeisler et al., , 1989 Wever, 1989) .
The present study has one surprising result. Whereas in most of the recently published articles (Arendt and Marks, 1983; Arendt et al., 1986 Arendt et al., , 1987 Petry et al., 1989) psychological alterations under melatonin treatment were most prominent in the determination of the effectiveness of this hormone, the present study indicates that melatonin has a greater influence on physiological than on psychological functions, since only minor significant differences were found in subjective ratings. Furthermore, at the end of each phase of the experiment, subjects were asked to guess whether they had ingested melatonin or placebo. Only four out of eight were correct; thus, the subjects did not recognize the beneficial effect of melatonin ingestion. The human circadian system was manipulated in this study under artificial conditions; therefore, the influence of external melatonin was anticipated to be more obvious in relation to other environmental time cues than under field conditions. Under laboratory conditions, melatonin intake provided an alleviating effect on jet lag in most subjects, but not in all. Bright light as a suppressor of melatonin secretion (Lewy et al., 1980) or as a zeitgeber (Wever et al., 1983; Czeisler et al., 1986) , as well as additional potential zeitgebers, may confound the influence of melatonin treatment in field studies, thus obscuring the potential benefit . In addition to the verification of the beneficial effect of melatonin treatment by investigating phase response curves (Lewy et al., in press), we recommend further research on the potential hormonal side effects, particularly when melatonin is taken over long time periods. Because possible side effects of an external input of the hormone melatonin on the human organism cannot be excluded today, we cannot recommend regular melatonin ingestion for the alleviation of jet lag (e.g., by commercial aircrews).
